Search research articles
Contact Us
Filters
Showing results (141-150 of 158) with videos related to
Page
of 16
Sort By:
Basic Research in Cardiology
|
August 29, 2013
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity
Jian Guan, Shikha Mishra, Jianru Shi, et al.
JACC. Cardiovascular Imaging
|
May 18, 2020
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
Sarah A M Cuddy, Paco E Bravo, Rodney H Falk, et al.
European Heart Journal. Cardiovascular Imaging
|
January 9, 2024
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis
Yesh Datar, Olivier F Clerc, Sarah A M Cuddy, et al.
European Heart Journal
|
September 2, 2021
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis
Oliver C Cohen, Andreia Ismael, Babita Pawarova, et al.
Circulation. Heart Failure
|
May 9, 2026
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy
Ahmad Masri, Francesco Cappelli, Margot K Davis, et al.
BMC Cardiovascular Disorders
|
February 14, 2022
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study
Ashutosh Wechalekar, Gunnar Antoni, Wasfi Al Azzam, et al.
Circulation. Cardiovascular Imaging
|
July 1, 2021
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
July 1, 2021
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
July 14, 2021
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
July 19, 2021
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 158) with videos related to
Sort By:
Page
of 16
Basic Research in Cardiology
|
August 29, 2013
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity
Jian Guan, Shikha Mishra, Jianru Shi, et al.
JACC. Cardiovascular Imaging
|
May 18, 2020
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
Sarah A M Cuddy, Paco E Bravo, Rodney H Falk, et al.
European Heart Journal. Cardiovascular Imaging
|
January 9, 2024
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis
Yesh Datar, Olivier F Clerc, Sarah A M Cuddy, et al.
European Heart Journal
|
September 2, 2021
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis
Oliver C Cohen, Andreia Ismael, Babita Pawarova, et al.
Circulation. Heart Failure
|
May 9, 2026
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy
Ahmad Masri, Francesco Cappelli, Margot K Davis, et al.
BMC Cardiovascular Disorders
|
February 14, 2022
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study
Ashutosh Wechalekar, Gunnar Antoni, Wasfi Al Azzam, et al.
Circulation. Cardiovascular Imaging
|
July 1, 2021
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
July 1, 2021
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
July 14, 2021
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
July 19, 2021
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, et al.
Page
of 16